Page 35 - Andreaf Wainer News Today

Mitchell Capital Management Co. decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 11.5% during the third quarter, HoldingsChannel reports. The fund owned 30,080 shares of the healthcare product maker’s stock after selling 3,921 shares during the quarter. Mitchell Capital Management Co.’s holdings in Abbott Laboratories were worth $2,913,000 as of […]

Amica Retiree Medical Trust lifted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 29.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,738 shares of the healthcare product maker’s stock after purchasing an additional 2,927 shares during the […]

Hamel Associates Inc. raised its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,808 shares of the healthcare product maker’s stock after buying an additional 800 […]

Amica Mutual Insurance Co. raised its position in Abbott Laboratories (NYSE:ABT – Free Report) by 30.8% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 102,445 shares of the healthcare product maker’s stock after purchasing an additional 24,126 shares during the period. Abbott Laboratories accounts for approximately […]

Abbott Laboratories (NYSE:ABT – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $4.50-4.70 for the period, compared to the consensus estimate of $4.63. Analyst Upgrades and Downgrades Several equities research analysts have issued reports on the stock. TheStreet upgraded shares of Abbott Laboratories from […]

Abbott Laboratories (NYSE:ABT – Get Free Report) posted its earnings results on Wednesday. The healthcare product maker reported $1.19 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.19, Yahoo Finance reports. Abbott Laboratories had a return on equity of 20.15% and a net margin of 12.92%. The firm had revenue of […]

Abbott Laboratories (NYSE:ABT – Get Free Report) announced its earnings results on Wednesday. The healthcare product maker reported $1.19 earnings per share for the quarter, hitting the consensus estimate of $1.19, Yahoo Finance reports. Abbott Laboratories had a net margin of 12.92% and a return on equity of 20.15%. The firm had revenue of $10.24 […]

Syon Capital LLC acquired a new stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 8,678 shares of the healthcare product maker’s stock, valued at approximately $840,000. Other institutional investors have also added […]

EverSource Wealth Advisors LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,369 shares of the healthcare product maker’s stock after selling 241 shares during the quarter. EverSource […]

Winthrop Advisory Group LLC cut its position in Abbott Laboratories (NYSE:ABT – Free Report) by 6.0% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 2,304 shares of the healthcare product maker’s stock after selling 147 shares during the quarter. Winthrop Advisory Group LLC’s holdings in Abbott Laboratories were worth $223,000 as of its […]